CSF2 and cancer: To further improve the immune response programming activity of such a cell-based vaccine intended for Cancer Transplant Immune Recognition Therapy, Granulocyte–Macrophage Colony-Stimulating Factor (GM-CSF) is used as immunological adjuvant, which is known to facilitate and increase antigen presentation in distinct types of cancers.